Patents Examined by Maureen Varina Driscoll
  • HER2 targeting agent
    Patent number: 11981747
    Abstract: An antibody or antigen-binding fragment thereof is disclosed. The antibody or antigen-binding fragment thereof binds to HER2 expressed on a cancer cell or a fragment of the HER2. A HER2-targeting agent containing any of the antibody or antigen-binding fragment thereof, and a pharmaceutical composition containing the HER2-targeting agent are disclosed.
    Type: Grant
    Filed: August 4, 2023
    Date of Patent: May 14, 2024
    Assignees: ONO PHARMACEUTICAL CO., LTD., TOHOKU UNIVERSITY
    Inventors: Yukinari Kato, Mika Kaneko, Daisuke Nakayama, Masayuki Kurogi
  • Anti-galectin-9 antibody and methods of use thereof
    Patent number: 11912772
    Abstract: An antibody targeting Galectin-9 is provided as are methods of using the same treatment of chronic immune conditions such as infections, inflammatory diseases and cancer, in particular malignant mesothelioma.
    Type: Grant
    Filed: July 12, 2019
    Date of Patent: February 27, 2024
    Assignee: University of Hawaii
    Inventors: Lishomwa C. Ndhlovu, Toshiro Niki